MIOREL 4 mg/2 ml, solution for injection (IM) in an ampoule 5 ampoules of 2 ml
Active ingredients: THIOCOLCHICOSIDE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 ampoules of 2 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIOREL 4 mg/2 ml, solution injectable (IM) en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 5 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- FARMACEUTICO SIT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Mar 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66305209CIP73690956CIP133400936909564Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| THIOCOLCHICOSIDEsolution | 4 mg · une ampoule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.